On leukocytes the CD55 and CD59 expression proved to be significantly higher for the HUS group treated with plasma separation and for both HUS and HUS/N groups treated with plasma separation and ECU compared to HC (Fig. 2 B; 15075, 14699 and 14255 vs. 10805, p = 0.0021, p = 0.0001 and p<0.0001 respectively for CD55; 14253, 12917 and 12705 vs. 11039, p = 0.0132, p = 0.0123 and p = 0.0060 respectively for CD59). The gene discussed is CD59; the disease is hemolytic-uremic syndrome.